急性心肌梗死合并室性心律失常的药物治疗分析  

Analysis of Medical Treatment for Acute Myocardial Infarction With Ventricular Arrhythmia

作　　者：蔡彬[1] CAI Bin(Department of Cardiology,Changsha Central Hospital,Changsha Hu’nan 410000,China)

机构地区：[1]长沙市中心医院心血管内科,湖南长沙410000

出　　处：《中国卫生标准管理》2020年第17期83-85,共3页China Health Standard Management

摘　　要：目的探究对急性心肌梗死合并室性心律失常患者实施胺碘酮与利多卡因两种药物的用药效果。方法以2018年6月—2019年9月为研究时间段,选择在本院接收治疗的60例急性心肌梗死合并室性心律失常患者为研究对象,结合患者治疗药物的差异,将60例患者分为常规组(n=30)和研究组(n=30)。常规组患者采用利多卡因治疗,研究组患者采用胺碘酮治疗,以两组患者的心率血压变化情况以及临床治疗有效率为指标,分析两种药物发挥的临床效用。结果研究结果表明,研究组患者治疗后的心率以及血压更加稳定,P<0.05;患者的临床治疗有效率更高,P<0.05。结论在对急性心肌梗死合并室性心律失常患者采用胺碘酮治疗,相比于利多卡因,药物治疗效果更加显著,药物安全性高,有助于患者病情更好的稳定。Objective To explore the effects of amiodarone and lidocaine on patients with acute myocardial infarction and ventricular arrhythmia.Methods From June 2018 to September 2019 as the research period,60 patients with acute myocardial infarction and ventricular arrhythmia who received treatment in our hospital were selected as the research object.Divided into regular group(n=30)and research group(n=30).The patients in the conventional group were treated with lidocaine,and the patients in the study group were treated with amiodarone.The clinical effects of the two drugs were analyzed based on the changes in heart rate and blood pressure in the two groups and the clinical effective rate.Results The results of the study showed that the heart rate and blood pressure of the patients in the study group were more stable after treatment,P<0.05;the clinical treatment efficiency of the patients was higher,P<0.05.Conclusion In patients with acute myocardial infarction and ventricular arrhythmia,amiodarone is used.Compared with lidocaine,the drug treatment effect is better and significant,and the drug safety is high.Popularize and apply during clinical treatment.

关 键 词：急性心肌梗死 室性心律失常 胺碘酮 利多卡因 心率 血压 治疗效果 

分 类 号：R541[医药卫生—心血管疾病]